Found 9 matching trials
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
PHASE2For this study, unfavorable intermediate risk prostate cancer patients will...
Location
NYU Langone Health
Prostate Medication, Metabolism and Gut Microbiota
PHASE4PROMED is a prospective, single center translational multiple cohort study ...
Location
Turku University Hospital
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
PHASE2This research study is studying a combination of hormonal therapy, chemothe...
Status
Active Not Recruiting
Location
University of California, San Diego
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
PHASE1This study is being conducted to assess the safety and tolerability of relu...
Location
Urological Associates of Southern Arizona, P.C.
FIRMAGON® Intensive Drug Monitoring
N/ATo evaluate the safety profile of FIRMAGON® (to fulfill the regulatory auth...
Location
China Primary Healthcare Foundation
Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix
PHASE2The main purpose of this clinical research study is to investigate if degar...
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
PHASE2Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regime...
Location
Urology Centers of Alabama
Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer
NADegarelix is an approved drug that is used to treat prostate cancer by lowe...
Location
Memorial Sloan Kettering Cancer Center
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
N/AThe purpose of this registry study is to longitudinally observe clinical ou...
Location
Akita University Hospital